🔎 Trials Near Me

Почетна › Метастатски карцином › Охајо › Columbus

Kliničke studije za Метастатски карцином u gradu Columbus, OH

25 studija za Метастатски карцином traži učesnike na lokacijama u gradu Columbus i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1/2
  • Clinical Study Site, Columbus
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07335497

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Тражи се учесникФаза 2
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • Columbus Oncology and Hematology Associates Inc, Columbus
  • и још 14
Сви узрасти · Оба пола · Ажурирано 12. 11. 2026. · NCT05564377

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Тражи се учесникФаза 1
  • Ohio State University Comprehensive Cancer Center, Columbus
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT05372614

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Тражи се учесникФаза 1/2
  • OSU Brain & Spine Hospital, Columbus
Узраст 12 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT05384626

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Тражи се учесникФаза 3
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07174336

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Тражи се учесникФаза 3
  • The Mark H Zangmeister Center, Columbus
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Hilliard · 10 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07213804

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Тражи се учесникФаза 3
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06119581

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Тражи се учесникФаза 1
  • The Ohio State University (OSU), Columbus
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05614739

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Тражи се учесникФаза 2/3
  • The Ohio State University Comprehensive Cancer Center, Columbus
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT06943755

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens

Тражи се учесникФаза 3
  • The Ohio State University Comprehensive Cancer Center, Columbus
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06127407

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Тражи се учесникФаза 2
  • Ohio State University, Columbus
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT06769698

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Тражи се учесникФаза 1
  • The Ohio State University Comprehensive Cancer Center, Columbus
Узраст 18 и старији · Мушкарци · Ажурирано 20. 10. 2026. · NCT07103018

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

Тражи се учесникФаза 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06311214

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

Тражи се учесникФаза 1
  • OSU Brain and Spine Hospital, Columbus
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06521554

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Тражи се учесникФаза 3
  • Stefanie Spielman Comprehensive Breast Center at Olentangy River Road, Columbus
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06757634

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Тражи се учесникФаза 3
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT07218380

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Тражи се учесникФаза 1
  • ALX Center 10, Columbus
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07085091

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

Тражи се учесникФаза 1/2
  • Ohio State University, Columbus
Узраст 12 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT05118789

SLV-154 Treatment of Advanced Cancers

Тражи се учесникФаза 1
  • The James Outpatient Care West Center, Columbus
Узраст 12 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT06771219

Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors

Тражи се учесникФаза 1
  • Ohio State University Comprehensive Cancer Center, Columbus
Узраст 18 и старији · Оба пола · Ажурирано 24. 8. 2026. · NCT05687136

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

Тражи се учесникФаза 1
  • Ohio State University Comprehensive Cancer Center, Columbus
Узраст 18 и старији · Оба пола · Ажурирано 3. 8. 2026. · NCT05687110

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Тражи се учесникФаза 3
  • Research Site, Columbus
  • Research Site, Hilliard · 10 ми удаљено
Узраст 18 и старији · Жене · Ажурирано 29. 7. 2026. · NCT07044336

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Тражи се учесникФаза 3
  • Ohio State University, James Cancer Hospital and Solove Research Institute, Columbus
Узраст 18 и старији · Оба пола · Ажурирано 9. 4. 2026. · NCT06064877

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Тражи се учесникФаза 2/3
  • The Ohio State University, Columbus
Сви узрасти · Оба пола · Ажурирано 2. 4. 2026. · NCT06581406

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Тражи се учесникОпсервациона студија
  • Massive Bio SYNERGY-AI site, Columbus
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

Studije za Метастатски карцином u drugim gradovima

Ostale studije u gradu Columbus

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.